Half-year report · Q2

Period2024-01-21 → 2024-07-20
Filed2024-09-03
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥117.6bn2024-01-21 → 2024-07-20Cons.Net sales
Revenue¥213.4bn2023-01-21 → 2024-01-20Cons.Net sales (5-year summary)
Revenue¥101.7bn2023-01-21 → 2023-07-20Cons.Net sales
Operating income¥2.3bn2024-01-21 → 2024-07-20Cons.Operating income
Operating income¥2.5bn2023-01-21 → 2023-07-20Cons.Operating income
Ordinary income¥1.4bn2024-01-21 → 2024-07-20Cons.Ordinary income
Ordinary income¥3.1bn2023-01-21 → 2024-01-20Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.8bn2023-01-21 → 2023-07-20Cons.Ordinary income
Profit before tax¥6.5bn2024-01-21 → 2024-07-20Cons.Income before income taxes
Profit before tax¥4.1bn2023-01-21 → 2023-07-20Cons.Income before income taxes
Net income (owners)¥4.9bn2024-01-21 → 2024-07-20Cons.Profit loss attributable to owners of parent
Net income (owners)¥4.4bn2023-01-21 → 2024-01-20Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥2.3bn2023-01-21 → 2023-07-20Cons.Profit loss attributable to owners of parent
Net income¥4.7bn2024-01-21 → 2024-07-20Cons.Profit loss
Net income¥2.4bn2023-01-21 → 2023-07-20Cons.Profit loss
Total assets¥199.3bnat 2024-07-20Cons.Assets
Total assets¥177.6bnat 2024-01-20Cons.Assets
Total assets¥182.1bnat 2023-07-20Cons.Total assets (5-year summary)
Total liabilities¥105.2bnat 2024-07-20Cons.Liabilities
Total liabilities¥86.1bnat 2024-01-20Cons.Liabilities
Net assets / equity¥94.2bnat 2024-07-20Cons.Net assets
Net assets / equity¥91.5bnat 2024-01-20Cons.Net assets
Net assets / equity¥87.8bnat 2023-07-20Cons.Net assets (5-year summary)
Cash and deposits¥36.5bnat 2024-07-20Cons.Cash and deposits
Cash and deposits¥32.4bnat 2024-01-20Cons.Cash and deposits
Cash & equivalents¥36.3bnat 2024-07-20Cons.Cash and cash equivalents
Cash & equivalents¥33.7bnat 2024-01-20Cons.Cash and cash equivalents
Cash & equivalents¥33.0bnat 2023-07-20Cons.Cash and cash equivalents
Cash & equivalents¥29.2bnat 2023-01-20dCons.Cash and cash equivalents
Operating cash flow¥5.5bn2024-01-21 → 2024-07-20Cons.Net cash provided by used in operating activities
Operating cash flow¥9.2bn2023-01-21 → 2024-01-20Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥2.7bn2023-01-21 → 2023-07-20Cons.Net cash provided by used in operating activities
Investing cash flow−¥4.1bn2024-01-21 → 2024-07-20Cons.Net cash provided by used in investment activities
Investing cash flow−¥1.2bn2023-01-21 → 2024-01-20Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow¥1.4bn2023-01-21 → 2023-07-20Cons.Net cash provided by used in investment activities
Financing cash flow¥1.8bn2024-01-21 → 2024-07-20Cons.Net cash provided by used in financing activities
Financing cash flow−¥3.2bn2023-01-21 → 2024-01-20Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥50m2023-01-21 → 2023-07-20Cons.Net cash provided by used in financing activities
EPS (basic)¥155.72024-01-21 → 2024-07-20Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥140.772023-01-21 → 2024-01-20Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥74.642023-01-21 → 2023-07-20Cons.Basic earnings loss per share (5-year summary)
Equity ratio46.4%at 2024-07-20Cons.Equity to asset ratio (5-year summary)
Equity ratio50.4%at 2024-01-20Cons.Equity to asset ratio (5-year summary)
Equity ratio47.2%at 2023-07-20Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 46
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2024-01-21 → 2024-07-20−¥167m
Reconciling Itemsreconcilingrevenue intersegment2024-01-21 → 2024-07-20−¥167m
Reconciling Itemsreconcilingsegment profit2024-01-21 → 2024-07-20−¥674m
jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segmentrevenue2024-01-21 → 2024-07-20¥73.0bn
jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segmentrevenue external2024-01-21 → 2024-07-20¥73.0bn
jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segmentrevenue intersegment2024-01-21 → 2024-07-20¥17m
jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segmentsegment profit2024-01-21 → 2024-07-20−¥238m
jpcrp040300-q2r_E00424-000Dy Do Pharmareportable segmentsegment profit2024-01-21 → 2024-07-20−¥295m
jpcrp040300-q2r_E00424-000Food Businessreportable segmentrevenue2024-01-21 → 2024-07-20¥11.1bn
jpcrp040300-q2r_E00424-000Food Businessreportable segmentrevenue external2024-01-21 → 2024-07-20¥11.1bn
jpcrp040300-q2r_E00424-000Food Businessreportable segmentrevenue intersegment2024-01-21 → 2024-07-20¥3m
jpcrp040300-q2r_E00424-000Food Businessreportable segmentsegment profit2024-01-21 → 2024-07-20¥899m
jpcrp040300-q2r_E00424-000International Beverage Businessreportable segmentrevenue2024-01-21 → 2024-07-20¥26.8bn
jpcrp040300-q2r_E00424-000International Beverage Businessreportable segmentrevenue external2024-01-21 → 2024-07-20¥26.8bn
jpcrp040300-q2r_E00424-000International Beverage Businessreportable segmentsegment profit2024-01-21 → 2024-07-20¥2.3bn
jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue2024-01-21 → 2024-07-20¥6.9bn
jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue external2024-01-21 → 2024-07-20¥6.7bn
jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue intersegment2024-01-21 → 2024-07-20¥146m
jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segmentsegment profit2024-01-21 → 2024-07-20¥324m
—segment totalrevenue2024-01-21 → 2024-07-20¥117.7bn
—segment totalrevenue external2024-01-21 → 2024-07-20¥117.6bn
—segment totalrevenue intersegment2024-01-21 → 2024-07-20¥167m
—segment totalsegment profit2024-01-21 → 2024-07-20¥3.0bn
Reconciling Itemsreconcilingrevenue2023-01-21 → 2023-07-20−¥204m
Reconciling Itemsreconcilingrevenue intersegment2023-01-21 → 2023-07-20−¥204m
Reconciling Itemsreconcilingsegment profit2023-01-21 → 2023-07-20−¥502m
jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segmentrevenue2023-01-21 → 2023-07-20¥74.3bn
jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segmentrevenue external2023-01-21 → 2023-07-20¥74.2bn
jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segmentrevenue intersegment2023-01-21 → 2023-07-20¥19m
jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segmentsegment profit2023-01-21 → 2023-07-20¥1.8bn
jpcrp040300-q2r_E00424-000Dy Do Pharmareportable segmentsegment profit2023-01-21 → 2023-07-20−¥296m
jpcrp040300-q2r_E00424-000Food Businessreportable segmentrevenue2023-01-21 → 2023-07-20¥10.8bn
jpcrp040300-q2r_E00424-000Food Businessreportable segmentrevenue external2023-01-21 → 2023-07-20¥10.8bn
jpcrp040300-q2r_E00424-000Food Businessreportable segmentrevenue intersegment2023-01-21 → 2023-07-20¥3m
jpcrp040300-q2r_E00424-000Food Businessreportable segmentsegment profit2023-01-21 → 2023-07-20¥776m
jpcrp040300-q2r_E00424-000International Beverage Businessreportable segmentrevenue2023-01-21 → 2023-07-20¥10.5bn
jpcrp040300-q2r_E00424-000International Beverage Businessreportable segmentrevenue external2023-01-21 → 2023-07-20¥10.5bn
jpcrp040300-q2r_E00424-000International Beverage Businessreportable segmentsegment profit2023-01-21 → 2023-07-20¥462m
jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue2023-01-21 → 2023-07-20¥6.4bn
jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue external2023-01-21 → 2023-07-20¥6.2bn
jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue intersegment2023-01-21 → 2023-07-20¥180m
jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segmentsegment profit2023-01-21 → 2023-07-20¥239m
—segment totalrevenue2023-01-21 → 2023-07-20¥102.0bn
—segment totalrevenue external2023-01-21 → 2023-07-20¥101.7bn
—segment totalrevenue intersegment2023-01-21 → 2023-07-20¥204m
—segment totalsegment profit2023-01-21 → 2023-07-20¥3.0bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 557
ItemContextValueUnit
Number of shares heldCurrentQuarterInstant_No2MajorShareholdersMember4023000
Shareholding ratioCurrentQuarterInstant_No2MajorShareholdersMember0.1264
Number of shares heldCurrentQuarterInstant_No3MajorShareholdersMember1933000
Shareholding ratioCurrentQuarterInstant_No3MajorShareholdersMember0.0607
Number of shares heldCurrentQuarterInstant_No4MajorShareholdersMember1243000
Shareholding ratioCurrentQuarterInstant_No4MajorShareholdersMember0.0390
Number of shares heldCurrentQuarterInstant_No5MajorShareholdersMember992000
Shareholding ratioCurrentQuarterInstant_No5MajorShareholdersMember0.0311
Number of shares heldCurrentQuarterInstant_No6MajorShareholdersMember990000
Shareholding ratioCurrentQuarterInstant_No6MajorShareholdersMember0.0311
Number of shares heldCurrentQuarterInstant_No7MajorShareholdersMember988000
Shareholding ratioCurrentQuarterInstant_No7MajorShareholdersMember0.0310
Number of shares heldCurrentQuarterInstant_No8MajorShareholdersMember500000
Shareholding ratioCurrentQuarterInstant_No8MajorShareholdersMember0.0157
Number of shares heldCurrentQuarterInstant_No9MajorShareholdersMember446000
Shareholding ratioCurrentQuarterInstant_No9MajorShareholdersMember0.0140
Number of shares heldCurrentQuarterInstant_No10MajorShareholdersMember413000
Shareholding ratioCurrentQuarterInstant_No10MajorShareholdersMember0.0129
Number of shares heldCurrentQuarterInstant16471000
Shareholding ratioCurrentQuarterInstant0.5176
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of voting rights issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember1313300
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesReciprocalHoldingSharesWithFullVotingRightsTreasurySharesEtcMember4000
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember31777200
Number of voting rights issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember317772
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember42500
Number of shares issued shares voting rightsCurrentQuarterInstant33137000
Number of voting rights issued shares voting rightsCurrentQuarterInstant317772
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row1Member1313300
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row1Member-
Total number of shares held treasury shares etcCurrentQuarterInstant_Row1Member1313300
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row1Member0.0396
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row2Member4000
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row2Member-
Total number of shares held treasury shares etcCurrentQuarterInstant_Row2Member4000
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row2Member0.0001
Number of shares held in own name treasury shares etcCurrentQuarterInstant1317300
Number of shares held in others names treasury shares etcCurrentQuarterInstant-
Total number of shares held treasury shares etcCurrentQuarterInstant1317300
Shareholding ratio treasury shares etcCurrentQuarterInstant0.0397
Cash and depositsPrior1YearInstant32367000000JPY
Cash and depositsCurrentQuarterInstant36461000000JPY
Notes and accounts receivable tradePrior1YearInstant22191000000JPY
Notes and accounts receivable tradeCurrentQuarterInstant34744000000JPY
Short term investment securitiesPrior1YearInstant12402000000JPY
Short term investment securitiesCurrentQuarterInstant10601000000JPY
Merchandise and finished goodsPrior1YearInstant10674000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-01-20pass rounding
balance sheet identityconsolidated 2024-07-20pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-01-20pass
statement vs summary · net assetsconsolidated 2024-07-20pass
statement vs summary · net income attributable to parentconsolidated 2023-01-21/2023-07-20pass
statement vs summary · net income attributable to parentconsolidated 2024-01-21/2024-07-20pass
statement vs summary · operating cash flowconsolidated 2023-01-21/2023-07-20pass
statement vs summary · operating cash flowconsolidated 2024-01-21/2024-07-20pass
statement vs summary · revenueconsolidated 2023-01-21/2023-07-20pass
statement vs summary · revenueconsolidated 2024-01-21/2024-07-20pass
statement vs summary · total assetsconsolidated 2024-01-20pass
statement vs summary · total assetsconsolidated 2024-07-20pass